CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy

CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Detaylı Bibliyografya
Yazar:	Eva, Israt Ara Jannat
Diğer Yazarlar:	Rahman, Kazi Fatema
Materyal Türü:	Tez
Dil:	English
Baskı/Yayın Bilgisi:	Brac University 2023
Konular:	CRISPR/Cas9 mechanism In vivo and in vitro modeling CRISPR/Cas9 delivery Mutation targeting in cancer and DMD Chromosomal rearrangement Mouse modeling Off-target limitation DMD mutation in human iPSCs Myoediting of DMD Therapeutic application of CRISPR Molecular genetics Cancer > Treatment
Online Erişim:	http://hdl.handle.net/10361/17764

Benzer Materyaller

A review on CRISPR-Cas system based applications in Oncology
Yazar:: Sadia, Mir
Baskı/Yayın Bilgisi: (2022)

CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
Yazar:: Maria, Amatul
Baskı/Yayın Bilgisi: (2020)

Comparative analysis of CRISPR-Cas systems of Yersinia pestis and Escherichia coli strains. (November 2020 – December 2021)
Yazar:: Nwabunwanne, Eze Uchenna
Baskı/Yayın Bilgisi: (2022)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
Yazar:: Shaikat, Mahdi Mubin
Baskı/Yayın Bilgisi: (2023)

CRISPR/Cas9 genome editing to treat sickle cell disease
Yazar:: Ullah, Mohammad
Baskı/Yayın Bilgisi: (2023)

A review on CRISPR Technology as an Antiviral Tool
Yazar:: Srishti, Sanjida Ahmed
Baskı/Yayın Bilgisi: (2023)

A review paper on Nanotechnology based strategies in the treatment of cancer
Yazar:: Rahman, Samia
Baskı/Yayın Bilgisi: (2022)

Biased acquisition of spacers by the CRISPR System of the V. cholerae
Yazar:: Supan, Erena Tuzneen, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Analysis and comparison between the Genome of CRISPR bacteriophages
Yazar:: Muntaha, Mumtasin
Baskı/Yayın Bilgisi: (2021)

Distribution of complete CRISPR-Cas systems in vibrio cholerae and its effect on presence of plasmid derived contigs in complete genome assemblies
Yazar:: Reza, Ratul
Baskı/Yayın Bilgisi: (2024)

Trend in approval of targeted biologics in the last two decades
Yazar:: Siddika, Khadiza
Baskı/Yayın Bilgisi: (2024)

Exploring the possible function and acquisition pattern of self-targeting Spacers: in five common infectious bacteria
Yazar:: Kenneth, Mutebi John
Baskı/Yayın Bilgisi: (2019)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
Yazar:: Bristy, Israt Zerin
Baskı/Yayın Bilgisi: (2021)

A comprehensive in silico investigation into the pathogenic SNPs in RTEL1 gene and their biological consequences
Yazar:: Tanshee, Rifah Rownak
Baskı/Yayın Bilgisi: (2023)

The microbial models of molecular biology
Yazar:: Davis, Rowland H.

SIRT6 and cancer stem cells: is there any implication?
Yazar:: Sarker, Tanosi
Baskı/Yayın Bilgisi: (2022)

Assessing the interspecies and intraspecies diversity of Cas1 and Cas3 proteins of the CRISPR-Cas system in vibrio cholera and Escherichia coli strains
Yazar:: Tabassum, Tahani, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Genetic disorders associated with mutations in bHLH transcription factors: a review
Yazar:: Joya, Mollika Bharadwaj
Baskı/Yayın Bilgisi: (2023)

Exploring of deletion mutation causative for Duchenne Muscular Dystrophy (DMD) in Bangladesh cohort
Yazar:: Eshaque, Tamannyat Binte
Baskı/Yayın Bilgisi: (2024)

A review on targeted therapies for lung cancer
Yazar:: Ashraf, Anushey
Baskı/Yayın Bilgisi: (2023)

Molecules associated with the development of lung cancer
Yazar:: Rahman, Adree, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Inside the human genome
Yazar:: Avise, John C.

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
Yazar:: Nahar, Kamrun
Baskı/Yayın Bilgisi: (2023)

State of Thalassemia in Bangladesh: a review
Yazar:: Reedoy, Md. Shariqul Islam
Baskı/Yayın Bilgisi: (2022)

Carcinogenesis

Molecular biology of cancer : mechanisms, targets, and therapeutics /
Yazar:: Pecorino, Lauren
Baskı/Yayın Bilgisi: (2012)

Molecular biology of the gene /
Baskı/Yayın Bilgisi: (2004)

Introduction to genetic analysis /
Baskı/Yayın Bilgisi: (2012)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
Yazar:: Meem, Manila
Baskı/Yayın Bilgisi: (2023)

iGenetics : a molecular approach /
Yazar:: Russell, Peter J.
Baskı/Yayın Bilgisi: (2006)

iGenetics : a molecular approach /
Yazar:: Russell, Peter J.
Baskı/Yayın Bilgisi: (2010)

Modern genetic analysis : integrating genes and genomes /
Yazar:: Griffiths, Anthony J. F.
Baskı/Yayın Bilgisi: (2002)

Targeted therapeutic options in the treatment of Breast Cancer
Yazar:: Alam, Kazi Tasnuva
Baskı/Yayın Bilgisi: (2022)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Yazar:: Paul, Pulock
Baskı/Yayın Bilgisi: (2024)

The current cancer situation in metropolitan Dhaka
Yazar:: Morshid, Golam
Baskı/Yayın Bilgisi: (2023)

Molecular biology and biotechnology : a guide for teachers /
Yazar:: Kreuzer, Helen
Baskı/Yayın Bilgisi: (2008)

Banking credit for farm inputs marketing business : macro perspective and micro realities / Bhupat M. Desai, N.V. Namboodiri.
Yazar:: Desai, B. M. 1938
Baskı/Yayın Bilgisi: (1996)

Repurposing Albendazole and Mebendazole, an antiparasitic drug in treating colorectal cancer- a review
Yazar:: Mondal, Shawon
Baskı/Yayın Bilgisi: (2023)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
Yazar:: Karim, Azrin
Baskı/Yayın Bilgisi: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Yazar:: Tania, Umme
Baskı/Yayın Bilgisi: (2023)